Bridgewater Associates’s Innospec IOSP Stock Holding History

Bridgewater Associates’s Portfolio IOSP Stock Details IOSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,950	Closed	-$434K	–	1085
2026 Q1	$434K	Buy	+5,950	New	+$463K	﹤0.01%	905

Other funds holding IOSP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Bridgewater Associates's IOSP Position: Q2 2026 in Review

Bridgewater Associates sold out of Innospec (IOSP) in Q2 2026, closing a stake of 5,950 shares — an estimated $434K sold.

Bridgewater Associates first reported a position in IOSP in Q1 2026 and held it in 1 quarter. The position peaked at $434K in Q1 2026. 281 funds tracked by Wall St. Rank hold IOSP as of Q2 2026.

Bridgewater Associates reported no remaining Innospec position as of Q2 2026 after selling out during the quarter.
Bridgewater Associates sold 5,950 Innospec shares in Q2 2026, an estimated $434K.
Bridgewater Associates first reported a position in Innospec in Q1 2026 and held it in 1 quarter.
Bridgewater Associates's Innospec position peaked at $434K in Q1 2026.
281 funds tracked by Wall St. Rank held Innospec as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.